Smart Bio Pharma

SmartBio is a biotechnology company focused on developing innovative oral delivery solutions for biologics and other complex therapeutics. The company's proprietary platform utilizes advanced material science to protect sensitive molecules from degradation in the gastrointestinal tract, enabling the oral administration of drugs that currently require injection. SmartBio's lead programs target metabolic diseases, including obesity and type 2 diabetes, by engineering oral versions of established peptide therapies. By improving patient compliance and expanding access to life-changing medicines, the company aims to redefine the standard of care for chronic conditions. SmartBio was founded by a team of renowned scientists from MIT and Harvard with expertise in drug delivery and bioengineering.